Search research articles
Contact Us
Filters
Showing results (1-10 of 85) with videos related to
Page
of 9
Sort By:
Biochemistry
|
November 18, 1986
Prochiral selectivity and intramolecular isotope effects in the cytochrome P-450 catalyzed omega-hydroxylation of cumene
K Sugiyama, W F Trager
Science (New York, N.Y.)
|
August 6, 1971
Oxidative N-dealkylation: a mannich intermediate in the formation of a new metabolite of lidocaine in man
G D Breck, W F Trager
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1996
Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction
K L Kunze, W F Trager
Chemical Research in Toxicology
|
September 1, 1993
Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline
K L Kunze, W F Trager
Journal of Medicinal Chemistry
|
January 1, 1978
Anomalous chiroptical properties of warfarin and phenprocoumon
E J Valente, W F Trager
The Journal of Clinical Investigation
|
May 1, 1970
Warfarin metabolism in man: identification of metabolites in urine
R J Lewis, W F Trager
Biochemistry
|
July 17, 1998
Mechanism-based inactivation of P450 2A6 by furanocoumarins
L L Koenigs, W F Trager
Journal of Medicinal Chemistry
|
April 1, 1985
Stereoselective metabolism of conformational analogues of warfarin by beta-naphthoflavone-inducible cytochrome P-450
L D Heimark, W F Trager
Journal of Medicinal Chemistry
|
August 1, 1984
The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system
L D Heimark, W F Trager
The Biochemical Journal
|
February 1, 1977
Improved non-parametric statistical methods for the estimation of Michaelis-Menten kinetic parameters by the direct linear plot
W R Porter, W F Trager
Page
of 9
Search research articles
Search
Showing results (1-10 of 85) with videos related to
Sort By:
Page
of 9
Biochemistry
|
November 18, 1986
Prochiral selectivity and intramolecular isotope effects in the cytochrome P-450 catalyzed omega-hydroxylation of cumene
K Sugiyama, W F Trager
Science (New York, N.Y.)
|
August 6, 1971
Oxidative N-dealkylation: a mannich intermediate in the formation of a new metabolite of lidocaine in man
G D Breck, W F Trager
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1996
Warfarin-fluconazole. III. A rational approach to management of a metabolically based drug interaction
K L Kunze, W F Trager
Chemical Research in Toxicology
|
September 1, 1993
Isoform-selective mechanism-based inhibition of human cytochrome P450 1A2 by furafylline
K L Kunze, W F Trager
Journal of Medicinal Chemistry
|
January 1, 1978
Anomalous chiroptical properties of warfarin and phenprocoumon
E J Valente, W F Trager
The Journal of Clinical Investigation
|
May 1, 1970
Warfarin metabolism in man: identification of metabolites in urine
R J Lewis, W F Trager
Biochemistry
|
July 17, 1998
Mechanism-based inactivation of P450 2A6 by furanocoumarins
L L Koenigs, W F Trager
Journal of Medicinal Chemistry
|
April 1, 1985
Stereoselective metabolism of conformational analogues of warfarin by beta-naphthoflavone-inducible cytochrome P-450
L D Heimark, W F Trager
Journal of Medicinal Chemistry
|
August 1, 1984
The preferred solution conformation of warfarin at the active site of cytochrome P-450 based on the CD spectra in octanol/water model system
L D Heimark, W F Trager
The Biochemical Journal
|
February 1, 1977
Improved non-parametric statistical methods for the estimation of Michaelis-Menten kinetic parameters by the direct linear plot
W R Porter, W F Trager
Page
of 9